Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3

作者: Sylvia CHRISTAKOS , Mihali RAVAL-PANDYA , Roman P. WERNYJ , Wen YANG

DOI: 10.1042/BJ3160361

关键词: CholecalciferolCalcitriol receptorTranscription factorReceptorSignal transductionSecosteroidBiochemistryBiologyRetinoid X receptorKinase

摘要: The biologically active metabolite of vitamin D (cholecalciferol), i.e. 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], is a secosteroid hormone whose mode action involves stereospecific interaction with an intracellular receptor protein (vitamin receptor; VDR). 1,25(OH)2D3 known to be principal regulator calcium homeostasis, and it has numerous other physiological functions including inhibition proliferation cancer cells, effects on secretion suppression T-cell cytokine production. Although the exact mechanisms involved in mediating many different are not completely defined, genomic actions involving VDR clearly major importance. Similar steroid receptors, phosphorylated; however, functional role phosphorylation remains determined. been reported regulated by also activation kinases A C, suggesting co-operativity between signal transduction pathways action. binds D-responsive elements (VDREs) 5´ flanking region target genes. It suggested that homodimerization can occur upon binding certain VDREs but VDR/retinoid X (RXR) heterodimer transactivating species. Other factors VDR-mediated transcription include chicken ovalbumin upstream promoter (COUP) factor, which silencing transcription, factor IIB, play following VDR/RXR heterodimerization. Newly identified D-dependent genes those for Ca2+/Mg2+-ATPase intestine p21 myelomonocytic U937 cell line. Elucidation multiple will area future research.

参考文章(17)
H F DeLuca, H Darwish, Vitamin D-regulated gene expression. Critical Reviews in Eukaryotic Gene Expression. ,vol. 3, pp. 89- 116 ,(1993)
M B Demay, M S Kiernan, H F DeLuca, H M Kronenberg, Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene. Molecular Endocrinology. ,vol. 6, pp. 557- 562 ,(1992) , 10.1210/MEND.6.4.1316548
Christopher M. Terpening, Carol A. Haussler, Peter W. Jurutka, Michael A. Galligan, Barry S. Komm, Mark R. Haussler, The vitamin D-responsive element in the rat bone Gla protein gene is an imperfect direct repeat that cooperates with other cis-elements in 1,25-dihydroxyvitamin D3- mediated transcriptional activation. Molecular Endocrinology. ,vol. 5, pp. 373- 385 ,(1991) , 10.1210/MEND-5-3-373
J. P. T. M. van Leeuwen, H. A. P. Pols, J. P. Schilte, T. J. Visser, J. C. Birkenhäger, Modulation by epidermal growth factor of the basal 1,25(OH)2D3 receptor level and the heterologous up-regulation of the 1,25(OH)2D3 receptor in clonal osteoblast-like cells. Calcified Tissue International. ,vol. 49, pp. 35- 42 ,(1991) , 10.1007/BF02555900
THERESA L. CHEN, PETER V. HAUSCHKA, DAVID FELDMAN, Dexamethasone increases 1,25-dihydroxyvitamin D3 receptor levels and augments bioresponses in rat osteoblast-like cells. Endocrinology. ,vol. 118, pp. 1119- 1126 ,(1986) , 10.1210/ENDO-118-3-1119
B. F. Luisi, W. X. Xu, Z. Otwinowski, L. P. Freedman, K. R. Yamamoto, P. B. Sigler, Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. ,vol. 352, pp. 497- 505 ,(2003) , 10.1038/352497A0
C H Jin, T Shinki, M H Hong, T Sato, A Yamaguchi, T Ikeda, S Yoshiki, E Abe, T Suda, 1 alpha,25-dihydroxyvitamin D3 regulates in vivo production of the third component of complement (C3) in bone. Endocrinology. ,vol. 131, pp. 2468- 2475 ,(1992) , 10.1210/ENDO.131.5.1425444